Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.
Mario E LacoutureElena GolevaNeil J ShahVeronica M RotembergLukas KraehenbuehlKwami F KetosugboTaha MerghoubTara MaierAlexander Sydat BangStephanie GuTrina SalvadorAndrea P MoyTaras LyubchenkoOlivia XiaoClifton F HallEvgeny V BerdyshevJames L CrooksRyan WeightJeffrey A KernDonald Y M LeungPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Distinct immunologic ircAE endotypes suggest actionable targets for precision medicine-based interventions.